116 related articles for article (PubMed ID: 18214051)
21. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
Matulonis UA; Krag KJ; Krasner CN; Atkinson T; Horowitz NS; Lee H; Penson RT
Gynecol Oncol; 2009 Feb; 112(2):394-9. PubMed ID: 19058838
[TBL] [Abstract][Full Text] [Related]
22. Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation.
Dvorák J; Melichar B; Hyspler R; Krcmová L; Urbánek L; Kalábová H; Kasparová M; Solichová D
Med Oncol; 2010 Sep; 27(3):690-6. PubMed ID: 19629763
[TBL] [Abstract][Full Text] [Related]
23. Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study.
Wright JD; Tian C; Mutch DG; Herzog TJ; Nagao S; Fujiwara K; Powell MA
Gynecol Oncol; 2008 Jun; 109(3):353-8. PubMed ID: 18407341
[TBL] [Abstract][Full Text] [Related]
24. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of selected carotenoids, alpha-tocopherol and retinol in human ovarian carcinoma ascitic fluid.
Schweigert FJ; Raila J; Sehouli J; Buscher U
Ann Nutr Metab; 2004; 48(4):241-5. PubMed ID: 15331882
[TBL] [Abstract][Full Text] [Related]
26. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
27. [Secondary myelodysplasia and leukemia following carboplatin and paclitaxel-containing chemotherapy for ovarian cancer].
Abe A; Ikawa H; Muguruma H; Maeda Y
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1795-8. PubMed ID: 18931592
[TBL] [Abstract][Full Text] [Related]
28. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
[TBL] [Abstract][Full Text] [Related]
29. Changes in alpha-tocopherol and retinol levels during cardiopulmonary bypass correlate with maximal arterial partial pressure of oxygen.
Valle-Giner I; Martí-Bonmatí E; Alegría-Torán A; Montero A; Morcillo EJ
Free Radic Res; 2007 Sep; 41(9):1061-7. PubMed ID: 17729125
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
[TBL] [Abstract][Full Text] [Related]
31. [Successful treatment of primary peritoneal carcinoma with paclitaxel and carboplatin combination chemotherapy].
Tohya T; Ujioka T; Yamaguchi M
Gan To Kagaku Ryoho; 2008 Jan; 35(1):153-5. PubMed ID: 18195548
[TBL] [Abstract][Full Text] [Related]
32. Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
Pignata S; Scambia G; Savarese A; Breda E; Sorio R; Pisano C; Lorusso D; Cognetti F; Vernaglia Lombardi A; Gebbia V; Scollo P; Morabito A; Signoriello G; Perrone F
Oncology; 2009; 76(1):49-54. PubMed ID: 19039248
[TBL] [Abstract][Full Text] [Related]
33. Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?
Gupta S
Nat Clin Pract Oncol; 2005 Feb; 2(2):80-1. PubMed ID: 16264879
[No Abstract] [Full Text] [Related]
34. Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patients.
Resasco M; Canobbio L; Trave F; Valenti G; Mazzoni A; Canti G; Boccardo F; Nicolin A
Anticancer Res; 1988; 8(6):1319-23. PubMed ID: 3218964
[TBL] [Abstract][Full Text] [Related]
35. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma.
Karpińska J; Mikołuć B; Motkowski R; Piotrowska-Jastrzebska J
J Pharm Biomed Anal; 2006 Sep; 42(2):232-6. PubMed ID: 16765550
[TBL] [Abstract][Full Text] [Related]
36. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
37. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
[TBL] [Abstract][Full Text] [Related]
38. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
[TBL] [Abstract][Full Text] [Related]
39. A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
Carter J; Durfee J
Gynecol Oncol; 2007 Dec; 107(3):586-9. PubMed ID: 17949798
[TBL] [Abstract][Full Text] [Related]
40. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G
Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]